Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs

Wegovy

FDA Approves Wegovy Pill, the First Oral GLP-1 for Weight Loss

Novo Nordisk sets an early-January U.S. launch at a $149 starting dose, giving it a near-term edge over Eli Lilly’s pending oral rival.

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves